Quantcast
Last updated on April 16, 2014 at 17:34 EDT

SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the World’s First Prototype for its Next Generation Application for Drug Safety Administration

December 5, 2012

JERUSALEM, December 5, 2012 /PRNewswire/ –

SafeCode Drug Technologies Corp. (OTCBB: SAFC)(the “Company”), a developer of
patent-pending voice recognition technology that reduces the risks of errors during the
administration of prescription medications, is pleased to announced it has identified and
is commencing to develop the world’s first prototype for its next generation application
for Drug Safety Administration. The prototype development and the technology application
is expected to be completed within 4-6 months and will be then demonstrated to worldwide
major drug container manufacturers for possible adoption to ensure a new generation drug
administration safety application.

The Company recently launched its new website which has also been optimized for
accessibility and easy navigation on smartphones and tablets as well as laptops and home
computers.

In conjunction with the website unveiling, the Company has published a new video
demonstrating the SafeCode voice-activation technology as a novel product candidate for
the medical industry. Investors are encouraged to view the video on the Company’s website
or on YouTube at http://www.youtube.com/watch?v=PEy9ygT6jaA.

Across the past month, the Company has been granted eligibility status by the
Depository Trust Company and commenced trading on the OTC Bulletin Boards.

“We are dedicated to providing a high-quality product and transparency to our
stakeholders. We are taking all necessary steps to meet these corporate goals and doing so
in an expeditious manner,” said Joel Klopfer, Chief Executive Officer at SafeCode Drug
Technologies Corp. “Accidental deaths resulting from administering incorrect medication
represent a multi-billion-dollar area of unmet need. We believe that we have a solution
with our patent-pending voice-recognition technology that will benefit manufacturers,
pharmacists and patients while building our corporate value. This is an exciting time for
our company and shareholders as we enter the commercialization phase. The new website was
important to us as it showcases the SafeCode solution while giving investors fast,
user-friendly access to information on our company.”

About SafeCode Drug Technologies

SafeCode Drug Technologies Corporation is the developer of a patent-pending voice
recognition technology that provides an essential degree of security that can effectively
prevent unauthorized administration of a prescription medication.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of
the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of
1934 as amended. All forward-looking statements are inherently uncertain, based on current
expectations and assumptions concerning future events or future performance of SafeCode
Drug Technologies Corp., and its technologies. In evaluating such statements, prospective
investors should review carefully various risks and uncertainties identified in this
release, as actual results may differ materially from those indicated. SafeCode Drug
Technologies Corp. public filings may be viewed at http://www.sec.gov

        Contact:
        Joel Klopfer
        Joel.Klofer1@gmail.com
        +9722-5021322

SOURCE Safecode Drug Technologies Corp.


Source: PR Newswire